Related references
Note: Only part of the references are listed.Comprehensive genomic characterization of head and neck squamous cell carcinomas
Michael S. Lawrence et al.
NATURE (2015)
Do high-risk human papillomaviruses cause oral cavity squamous cell carcinoma?
H. Mirghani et al.
ORAL ONCOLOGY (2015)
Are common fragile sites merely structural domains or highly organized functional'' units susceptible to oncogenic stress?
Alexandros G. Georgakilas et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
Improved Survival with Bevacizumab in Advanced Cervical Cancer
Krishnansu S. Tewari et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Measurement of Neutralizing Serum Antibodies of Patients Vaccinated with Human Papillomavirus L1 or L2-Based Immunogens Using Furin-Cleaved HPV Pseudovirions
Joshua W. Wang et al.
PLOS ONE (2014)
microRNAs are biomarkers of oncogenic human papillomavirus infections
Xiaohong Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Immune response to the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose or 3-dose schedule up to 4 years after vaccination Results from a randomized study
Barbara Romanowski et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
Immunogenicity of 2 Doses of HPV Vaccine in Younger Adolescents vs 3 Doses in Young Women A Randomized Clinical Trial
Simon R. M. Dobson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Head and Neck Cancer Stem Cells: The Effect of HPVAn In Vitro and Mouse Study
Alice L. Tang et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2013)
An unbiased in vivo screen reveals multiple transcription factors that control HPV E6-regulated hTERT in keratinocytes
Mei Xu et al.
VIROLOGY (2013)
The HPV16 oncogenes cause aberrant stem cell mobilization
Stella Michael et al.
VIROLOGY (2013)
Cancer-initiating cells derived from established cervical cell lines exhibit stem-cell markers and increased radioresistance
Jacqueline Lopez et al.
BMC CANCER (2012)
The role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer
C. B. Lajer et al.
BRITISH JOURNAL OF CANCER (2012)
Human papillomaviruses and the specificity of PDZ domain targeting
David Pim et al.
FEBS JOURNAL (2012)
Comprehensive Analysis of Host Cellular Interactions with Human Papillomavirus E6 Proteins Identifies New E6 Binding Partners and Reflects Viral Diversity
Elizabeth A. White et al.
JOURNAL OF VIROLOGY (2012)
Understanding and learning from the success of prophylactic human papillomavirus vaccines
John T. Schiller et al.
NATURE REVIEWS MICROBIOLOGY (2012)
Treatment of Cervical Intraepithelial Neoplasia With Topical Imiquimod A Randomized Controlled Trial
Christoph Grimm et al.
OBSTETRICS AND GYNECOLOGY (2012)
Systematic identification of interactions between host cell proteins and E7 oncoproteins from diverse human papillomaviruses
Elizabeth A. White et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease
Beatriz Serrano et al.
INFECTIOUS AGENTS AND CANCER (2012)
Regulation of cellular miRNA expression by human papillomaviruses
Zhi-Ming Zheng et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2011)
Silencing oncogene expression in cervical cancer stem-like cells inhibits their cell growth and self-renewal ability
W. Gu et al.
CANCER GENE THERAPY (2011)
Human papillomavirus type 16 E6 induces cervical cancer cell migration through the p53/microRNA-23b/urokinase-type plasminogen activator pathway
C. L. Au Yeung et al.
ONCOGENE (2011)
Phase II trial of imiquimod and HPV therapeutic vaccination in patients with vulval intraepithelial neoplasia
S. Daayana et al.
BRITISH JOURNAL OF CANCER (2010)
Oral diindolyl methane (DIM): Pilot evaluation of a nonsurgical treatment for cervical dysplasia
Giuseppe Del Priore et al.
GYNECOLOGIC ONCOLOGY (2010)
Reduced miR-34a Expression in Normal Cervical Tissues and Cervical Lesions With High-Risk Human Papillomavirus Infection
Baohua Li et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2010)
Phase II, Open-Label Study of Pazopanib or Lapatinib Monotherapy Compared With Pazopanib Plus Lapatinib Combination Therapy in Patients With Advanced and Recurrent Cervical Cancer
Bradley J. Monk et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Multiple E2F-Induced MicroRNAs Prevent Replicative Stress in Response to Mitogenic Signaling
Maria J. Bueno et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
Human papillomavirus oncoproteins: pathways to transformation
Cary A. Moody et al.
NATURE REVIEWS CANCER (2010)
Topical treatment of CIN 2+by cidofovir: Results of a phase II, double-blind, prospective, placebo-controlled study
C. Van Pachterbeke et al.
GYNECOLOGIC ONCOLOGY (2009)
Oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6
Xiaohong Wang et al.
RNA (2009)
Papillomaviruses in the causation of human cancers - a brief historical account
Harald zur Hausen
VIROLOGY (2009)
Oncogenic activities of human papillomaviruses
Margaret E. McLaughlin-Drubin et al.
VIRUS RESEARCH (2009)
Stem-cell-abundant proteins Nanog, Nucleostemin and Musashi1 are highly expressed in malignant cervical epithelial cells
Feng Ye et al.
BMC CANCER (2008)
Inhibition of apoptosis in human laryngeal cancer cells by E6 and E7 oncoproteins of human papillomavirus 16
Han Ching Liu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
E6 Proteins from Multiple Human Betapapillomavirus Types Degrade Bak and Protect Keratinocytes from Apoptosis after UVB Irradiation
Michael P. Underbrink et al.
JOURNAL OF VIROLOGY (2008)
Direct association of the HPV16 E7 oncoprotein with cyclin A/CDK2 and cyclin E/CDK2 complexes
Christine L. Nguyen et al.
VIROLOGY (2008)
Bevacizumab combination therapy in heavily pretreated, recurrent cervical cancer
Jason D. Wright et al.
GYNECOLOGIC ONCOLOGY (2006)
Accelerated degradation of FADD and procaspase 8 in cells expressing human papilloma virus 16 E6 impairs TRAIL-mediated apoptosis
T. O. Garnett et al.
CELL DEATH AND DIFFERENTIATION (2006)
Association of the human papillomavirus type 16 E7 oncoprotein with the 600-kDa retinoblastoma protein-associated factor, p600
KW Huh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
E6 oncoprotein represses p53-dependent gene activation via inhibition of protein acetylation independently of inducing p53 degradation
MC Thomas et al.
MOLECULAR CELL (2005)
Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets
BP Lewis et al.
CELL (2005)
The binding of histone deacetylases and the integrity of zinc finger-like motifs of the E7 protein are essential for the life cycle of human papillomavirus type 31
MS Longworth et al.
JOURNAL OF VIROLOGY (2004)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
HPV-18 confers resistance to TNF-α in organotypic cultures of human keratinocytes
E Boccardo et al.
VIROLOGY (2004)
The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cycle
S Duensing et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein - Implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis
JS Park et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
